Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Telix Pharmaceuticals Limited Shares: Is the Market Underestimating This Healthcare Growth Story?

• For the first half of 2026, Telix reportedRevenueof US$477 million with adjusted EBITDA of US$52 million, and its second-quarter revenue was US$247 million, keeping its...

Aditi Sarkar | 02 September 2026

Could Doctor Care Anywhere Group PLC Shs Be the Next ASX Stock to Surprise Investors?

• For the first half of 2026, Doctor Care Anywhere reportedRevenueof £20.4 million with EBITDA up 27% and freeCash Flowmore than doubling, and it acquired a weight-management...

Aditi Sarkar | 02 September 2026

Polynovo Limited (ASX:PNV): Why This Under-the-Radar ASX Stock Could Be One to Watch in September

For FY26, PolyNovo (ASX:PNV) reported recordRevenueof around A$150 million and turned free-cash-flow positive after record United States sales, a significant milestone for a company that has been investing heavily to grow. The result reflected continued commercial expansion of its NovoSorb wound-care portfolio, particularly in …

Sonal Goyal | 02 September 2026

Medical Developments International Limited (ASX:MVP): Could the Next Clinical or Commercial Catalyst Spark a Major Re-Rating?

In its third-quarter FY26 update, to 31 March 2026, Medical Developments (ASX:MVP) reported totalRevenueup 19% to A$10.5 million, with pain-management revenue — driven primarily by Penthrox — up 47% to A$8.4 million, and it generated positiveOperating Cash Flowof A$2.5 million in the quarter. Penthrox …

Sonal Goyal | 02 September 2026

Could Mach7 Technologies Ltd Be the Next ASX Stock to Surprise Investors?

Mach7's (ASX:M7T) first-half FY26 result showed revenue down 23% amid a strategic reset as the company shifted itsBusinesstoward recurring subscription revenue, which can depress reported revenue in the transition. By the fourth quarter of FY26, however, it reported a positive operating-cash-flow quarter, with annualRecurring …

Sonal Goyal | 02 September 2026

Amplia Therapeutics Ltd Shares: Is the Market Underestimating This Healthcare Growth Story?

Amplia reported that its ACCENT trial of narmafotinib plus chemotherapy in pancreatic cancer produced multiple complete responses — cases where tumours were no longer detectable — along with improved overall survival data, and it presented ACCENT results at the 2026 ASCO Gastrointestinal Cancer Symposium. …

Sonal Goyal | 02 September 2026

Global Health Limited (ASX:GLH): What Comes Next After a Sharp Session Decline?

A difficult session pushed Global Health Limited (ASX:GLH) to AUD 0.05, a decline of 19.36%. The market move is one part of the picture; the company’s own announcements keep the focus on financial performance and funding position.

Aditi Sarkar | 02 September 2026

Why Integral Diagnostics Ltd Is One ASX Healthcare Stock Investors May Be Watching Closely

For FY26, Integral Diagnostics (ASX:IDX) reportedRevenueup 25.6% to A$788.7 million, with organic Australian revenue up 7.4%, and operating EBITDA up 30.3% to A$164.8 million at aMarginof 20.9%. Operating net profit after tax rose 50.1% to A$47.4 million, and statutory net profit improved sharply to …

Sonal Goyal | 02 September 2026

Clinuvel Pharmaceuticals Limited Shares: Is the Market Underestimating This Healthcare Growth Story?

For FY26, to 30 June 2026, Clinuvel reportedRevenuefrom ordinary activities of A$94.0 million, down 1%, and net profit after tax of A$33.9 million, down 6%, while cash reserves grew 12% to A$252 million and netAssetsreached A$272.9 million. It declared aDividendof 5.0 cents per share …

Sonal Goyal | 02 September 2026

Could CSL Limited Be the Next ASX Stock to Surprise Investors?

For FY26, CSL reported totalRevenueof US$15.8 billion, down 1% at constant currency, with underlying net profit after tax andAmortisationof US$3.1 billion, down 2%. However, US$7.1 billion of pre-tax impairments and US$799 million of restructuring costs drove a statutory net loss after tax of US$2.6 …

Sonal Goyal | 02 September 2026
Support

Hi! How can we help you today?

Loading…